A A Spasov - JoVE Visualize

Showing results (131-140 of 156) with videos related to

Pageof 16

Sort By:

Bulletin of Experimental Biology and Medicine|July 2, 2024

Antiplatelet and Antithrombotic Properties of Compound L-36, a 6H-1,3,4-Thiadiazine DerivativeV S Sirotenko, A A Spasov, A F Kucheryavenko, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|April 4, 2007

[Comparative study of the antiarrhythmic activity of L-, D-and DL-stereoisomers of potassium magnesium aspartate]A A Spasov, I N Iezhitsa, N V Zhuravleva, et al.

Herald of the Russian Academy of Sciences|September 12, 2022

Development of Drugs with Direct Antiviral Action Based on Azaheterocyclic SystemsV N Charushin, V L Rusinov, M V Varaksin, et al.

Vestnik Otorinolaringologii|October 8, 1999

[Clinical and experimental rationale of policatan administration in upper respiratory tract inflammation]A A Spasov, N K Sanzharovskaia, O V Ostrovskiĭ, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|April 13, 1999

[The mechanisms of the neurotropic action of bromantan]I S Morozov, G S Pukhova, N A Avdulov, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|June 28, 2018

NEUROPROTECTIVE PROPERTIES OF A NEW INHIBITOR OF NA+/H+ EXCHANGER (COMPOUND RU-1355) ON THE MODEL OF FOCAL ISCHEMIA IN RATSA A Spasov, V U Murav'eva, N A Gurova, et al.

Bulletin of Experimental Biology and Medicine|March 28, 2012

Correction of furosemide-induced magnesium deficiency with different stereoisomers of organic magnesium salts: a comparative studyA A Spasov, A A Ozerov, I N Iezhitsa, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|October 18, 2014

[Pharmacokinetic and analgesic properties of tabletized dosage form of RU-1205-new imidazobenzimidazole derivative with kappa agonist activity]A A Spasov, L A Smirnova, O Iu Grechko, et al.

Patologicheskaia Fiziologiia I Eksperimental'Naia Terapiia|September 5, 2013

[Experimental evidence of magnesium salts for treatment of calcium oxalate nephrolithiasis in an animal model based on sodium oxalate and a cyclooxygenase 2 selective inhibitor]A A Spasov, I N Iezhitsa, M V Kharitonova, et al.

Urologiia (Moscow, Russia : 1999)|May 14, 2013

[The effectiveness of certain magnesium salts in nephrolithiasis caused by the use of sodium oxalate and celecoxib]A A Spasov, I N Iezhitsa, M V Kharitonova, et al.

Pageof 16

Showing results (131-140 of 156) with videos related to

Sort By:

Pageof 16

Bulletin of Experimental Biology and Medicine|July 2, 2024

Antiplatelet and Antithrombotic Properties of Compound L-36, a 6H-1,3,4-Thiadiazine DerivativeV S Sirotenko, A A Spasov, A F Kucheryavenko, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|April 4, 2007

[Comparative study of the antiarrhythmic activity of L-, D-and DL-stereoisomers of potassium magnesium aspartate]A A Spasov, I N Iezhitsa, N V Zhuravleva, et al.

Herald of the Russian Academy of Sciences|September 12, 2022

Development of Drugs with Direct Antiviral Action Based on Azaheterocyclic SystemsV N Charushin, V L Rusinov, M V Varaksin, et al.

Vestnik Otorinolaringologii|October 8, 1999

[Clinical and experimental rationale of policatan administration in upper respiratory tract inflammation]A A Spasov, N K Sanzharovskaia, O V Ostrovskiĭ, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|April 13, 1999

[The mechanisms of the neurotropic action of bromantan]I S Morozov, G S Pukhova, N A Avdulov, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|June 28, 2018

NEUROPROTECTIVE PROPERTIES OF A NEW INHIBITOR OF NA+/H+ EXCHANGER (COMPOUND RU-1355) ON THE MODEL OF FOCAL ISCHEMIA IN RATSA A Spasov, V U Murav'eva, N A Gurova, et al.

Bulletin of Experimental Biology and Medicine|March 28, 2012

Correction of furosemide-induced magnesium deficiency with different stereoisomers of organic magnesium salts: a comparative studyA A Spasov, A A Ozerov, I N Iezhitsa, et al.

Eksperimental'Naia I Klinicheskaia Farmakologiia|October 18, 2014

[Pharmacokinetic and analgesic properties of tabletized dosage form of RU-1205-new imidazobenzimidazole derivative with kappa agonist activity]A A Spasov, L A Smirnova, O Iu Grechko, et al.

Patologicheskaia Fiziologiia I Eksperimental'Naia Terapiia|September 5, 2013

[Experimental evidence of magnesium salts for treatment of calcium oxalate nephrolithiasis in an animal model based on sodium oxalate and a cyclooxygenase 2 selective inhibitor]A A Spasov, I N Iezhitsa, M V Kharitonova, et al.

Urologiia (Moscow, Russia : 1999)|May 14, 2013

[The effectiveness of certain magnesium salts in nephrolithiasis caused by the use of sodium oxalate and celecoxib]A A Spasov, I N Iezhitsa, M V Kharitonova, et al.

Pageof 16